• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket

    1/17/24 8:18:56 AM ET
    $ADAG
    $BANL
    $DATS
    $ESLA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Oil Refining/Marketing
    Energy
    Get the next $ADAG alert in real time by email

    Shares of DatChat, Inc. (NASDAQ:DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock.

    DatChat shares dipped 33.1% to $2.13 in pre-market trading

    Here are some other stocks moving in pre-market trading.

    Gainers

    • RiskOn International, Inc. (NASDAQ:ROI) shares rose 51.3% to $0.2250 in pre-market trading.
    • Meta Materials Inc. (NASDAQ:MMAT) shares jumped 33.2% to $0.0966 in pre-market trading after surging over 20% on Tuesday.
    • LQR House Inc. (NASDAQ:LQR) gained 25.2% to $2.53 in pre-market trading after dipping 45% on Tuesday. LQR House announced an increase of its share buyback program to $5 million.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares climbed 19.3% to $0.1514 in pre-market trading after falling more than 9% on Tuesday.
    • Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) shares gained 15.7% to $0.2950 in pre-market trading after dipping 13% on Tuesday.
    • Solid Power, Inc. (NASDAQ:SLDP) gained 15.1% to $1.37 in pre-market trading. Solid Power deepened its partnership with SK On with three new agreements.
    • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) surged 10.7% to $0.6599 in pre-market trading. Salarius Pharmaceuticals said that the U.S. Patent and Trademark Office has issued U.S. Patent No. 11,773,080, titled “Deuterium-enriched isoindolinonyl-azepanediones and related compounds and methods of treating medical disorders using same.”
    • Estrella Immunopharma, Inc. (NASDAQ:ESLA) gained 9.4% to $1.40 in pre-market trading after gaining around 4% on Tuesday.
    • Ocean Biomedical, Inc. (NASDAQ:OCEA) surged 9.3% to $0.63 in pre-market trading after dipping over 8% on Tuesday.
    • Natera, Inc. (NASDAQ:NTRA) gained 8.3% to $68.10 in pre-market trading. Natera announced that jury in US District Court for W. District of Texas ruled in patent infringement lawsuit brought by Ravgen, awarding $57 million in damages, below the $410 million sought.

    Losers

    • Phunware, Inc. (NASDAQ:PHUN) shares fell 58.7% to $0.1735 in pre-market trading. Phunware announced pricing of $7.0 million registered direct offering priced at-the-market under Nasdaq rules.
    • Remark Holdings, Inc. (NASDAQ:MARK) shares fell 21.4% to $0.5324 in pre-market trading after jumping around 48% on Tuesday.
    • MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) shares fell 12.4% to $0.1779 in pre-market trading. MyMD Pharmaceuticals has been granted Canadian patent number 3013634 Titled "Methods Of Increasing Hair Growth and Improving Hair Appearance."
    • Elevai Labs, Inc. (NASDAQ:ELAB) fell 12.4% to $1.21 in pre-market trading. ELEVAI Labs shares fell around 19% on Tuesday after the company announced it signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio.
    • Verb Technology Company, Inc. (NASDAQ:VERB) shares declined 10.7% to $0.1160 in pre-market trading after gaining around 3% on Tuesday.
    • Adagene Inc. (NASDAQ:ADAG) shares fell 10.3% to $3.38 in pre-market trading after the company announced interim results from masked anti-CTLA-4 SAFEbody ADG126 in combination with pembrolizumab in metastatic microsatellite-stable colorectal cancer.
    • Salem Media Group, Inc. (NASDAQ:SALM) fell 9.7% to $0.30 in pre-market trading. Salem Media, last month, announced it will voluntarily delist from the Nasdaq Global Market.
    • Rail Vision Ltd. (NASDAQ:RVSN) fell 7.7% to $1.55 in pre-market trading after gaining over 20% on Tuesday.
    • CBL International Limited (NASDAQ:BANL) fell 7.4% to $1.40 in pre-market trading after gaining around 12% on Tuesday.


    Now Read This: U.S. Bancorp, Charles Schwab And 3 Stocks To Watch Heading Into Wednesday

    Get the next $ADAG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADAG
    $BANL
    $DATS
    $ESLA

    CompanyDatePrice TargetRatingAnalyst
    Natera Inc.
    $NTRA
    1/7/2026$300.00Buy
    Citigroup
    Natera Inc.
    $NTRA
    12/2/2025$265.00Overweight
    Morgan Stanley
    Adagene Inc.
    $ADAG
    11/24/2025$9.00Buy
    Guggenheim
    Natera Inc.
    $NTRA
    10/27/2025$172.00Underperform → Neutral
    BNP Paribas Exane
    Natera Inc.
    $NTRA
    9/22/2025$175.00Equal Weight
    Wells Fargo
    Adagene Inc.
    $ADAG
    8/6/2025$7.00Outperform
    Leerink Partners
    Natera Inc.
    $NTRA
    3/13/2025$251.00Outperform
    RBC Capital Mkts
    Adagene Inc.
    $ADAG
    1/31/2025Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ADAG
    $BANL
    $DATS
    $ESLA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO AND PRESIDENT Chapman Steven Leonard sold $20,770,419 worth of shares (90,024 units at $230.72), decreasing direct ownership by 42% to 123,156 units (SEC Form 4)

    4 - Natera, Inc. (0001604821) (Issuer)

    2/4/26 9:35:07 PM ET
    $NTRA
    Medical Specialities
    Health Care

    CHIEF FINANCIAL OFFICER Brophy Michael Burkes sold $1,580,926 worth of shares (6,939 units at $227.83), decreasing direct ownership by 12% to 52,120 units (SEC Form 4)

    4 - Natera, Inc. (0001604821) (Issuer)

    2/4/26 9:35:05 PM ET
    $NTRA
    Medical Specialities
    Health Care

    PRESIDENT, CLINICALDIAGNOSTICS Moshkevich Solomon sold $1,072,538 worth of shares (4,639 units at $231.20), decreasing direct ownership by 3% to 137,847 units (SEC Form 4)

    4 - Natera, Inc. (0001604821) (Issuer)

    2/4/26 9:35:09 PM ET
    $NTRA
    Medical Specialities
    Health Care

    $ADAG
    $BANL
    $DATS
    $ESLA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Natera Reports Fourth Quarter and Full Year 2025 Financial Results

    Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the fourth quarter and full year ended December 31, 2025. Recent Financial Highlights Generated total revenues of $665.5 million in the fourth quarter of 2025, compared to $476.1 million in the fourth quarter of 2024, an increase of 39.8%. Product revenues grew 39.8% over the same period. Generated a gross margin1 of 66.9% in the fourth quarter of 2025, compared to a gross margin1 of 62.9% in the fourth quarter of 2024. Generated total revenues of $2,306.1 million in the full year 2025, compared to $1,696.9 million in the full year 2024, an increase of 35.9%.

    2/26/26 4:05:00 PM ET
    $NTRA
    Medical Specialities
    Health Care

    Salem Media Presents 2026 Stuart Epperson Award for Excellence in Christian Media Posthumously to Dr. John MacArthur at NRB

    CAMARILLO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Salem Media (OTCQX:SALM) announced today that it has posthumously presented the 2026 Stuart Epperson Award for Excellence in Christian Media to Dr. John Fullerton MacArthur Jr., honoring more than five decades of faithful Gospel ministry and global impact through Christian media. The award was presented during a private gathering at the 2026 National Religious Broadcasters (NRB) Convention, recognizing Dr. MacArthur as the fourth recipient of the honor. Dr. MacArthur passed away on July 14, 2025, at the age of 86. Established in 2024, the Stuart Epperson Award honors the legacy of Salem co-founder and longtime chairman Stuart Epperson

    2/25/26 9:00:00 AM ET
    $SALM
    Broadcasting
    Consumer Discretionary

    Solid Power Reports Full Year 2025 Results

    Solid Power, Inc. (NASDAQ:SLDP), a leading developer of solid-state battery technology, today announced its operational and financial results for the full year 2025 and provided its outlook and objectives for 2026. Recent Business Highlights Announced a Joint Evaluation Agreement with Samsung SDI and BMW to progress the development of all-solid-state batteries, marking meaningful progress on our path towards commercialization and validating our electrolyte sampling efforts. Conducted detailed design for a continuous electrolyte production pilot line, which we expect to install and commission by the end of 2026. Executed on our line installation agreement with SK On, completing fa

    2/24/26 4:05:00 PM ET
    $SLDP
    Industrial Machinery/Components
    Miscellaneous

    $ADAG
    $BANL
    $DATS
    $ESLA
    SEC Filings

    View All

    Natera Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Natera, Inc. (0001604821) (Filer)

    2/26/26 4:06:28 PM ET
    $NTRA
    Medical Specialities
    Health Care

    SEC Form S-8 filed by Solid Power Inc.

    S-8 - Solid Power, Inc. (0001844862) (Filer)

    2/25/26 4:15:45 PM ET
    $SLDP
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 10-K filed by Solid Power Inc.

    10-K - Solid Power, Inc. (0001844862) (Filer)

    2/25/26 8:57:06 AM ET
    $SLDP
    Industrial Machinery/Components
    Miscellaneous

    $ADAG
    $BANL
    $DATS
    $ESLA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup initiated coverage on Natera with a new price target

    Citigroup initiated coverage of Natera with a rating of Buy and set a new price target of $300.00

    1/7/26 9:12:45 AM ET
    $NTRA
    Medical Specialities
    Health Care

    Morgan Stanley resumed coverage on Natera with a new price target

    Morgan Stanley resumed coverage of Natera with a rating of Overweight and set a new price target of $265.00

    12/2/25 8:28:19 AM ET
    $NTRA
    Medical Specialities
    Health Care

    Guggenheim initiated coverage on Adagene with a new price target

    Guggenheim initiated coverage of Adagene with a rating of Buy and set a new price target of $9.00

    11/24/25 8:15:55 AM ET
    $ADAG
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADAG
    $BANL
    $DATS
    $ESLA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hanish Arnold C bought $3,740 worth of shares (5,000 units at $0.75) (SEC Form 4)

    4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)

    11/24/25 5:08:13 PM ET
    $SLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Exec VP Finance, CFO Rosenblum Mark J bought $16,000 worth of shares (20,000 units at $0.80), increasing direct ownership by 11,299% to 20,177 units (SEC Form 4)

    4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)

    11/20/25 4:42:09 PM ET
    $SLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Myman Darin M bought $4,392 worth of shares (2,000 units at $2.20), increasing direct ownership by 1% to 184,516 units (SEC Form 4)

    4 - Myseum, Inc. (0001648960) (Issuer)

    8/28/25 6:07:47 PM ET
    $DATS
    Telecommunications Equipment
    Telecommunications

    $ADAG
    $BANL
    $DATS
    $ESLA
    Leadership Updates

    Live Leadership Updates

    View All

    Townhall Media Announces Larry O'Connor as New Editor of Townhall.com

    WASHINGTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Townhall Media, a subsidiary of Salem Media Group (OTCQX:SALM), today announced the appointment of Larry O'Connor as Editor of Townhall.com, effective immediately. Larry O'Connor is a trusted conservative voice known for credibility, clarity, and consistency, earning the respect of audiences, peers, and industry leaders alike. He brings decades of experience across writing, podcasts, broadcast, and live events, along with a proven record of leadership, audience growth, and editorial excellence to one of the nation's most influential conservative platforms. O'Connor is known for his deep understanding of the political and cultural landscape. H

    1/20/26 9:15:00 AM ET
    $SALM
    Broadcasting
    Consumer Discretionary

    Octave Bioscience Expands Leadership Team with Appointment of Kirk Stockwood Senior Vice President, Commercial

    Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker driven solutions for multiple sclerosis, Parkinson's disease and other neurodegenerative diseases today announced the appointment of Kirk Stockwood as Senior Vice President, Commercial. Mr. Stockwood will spearhead Octave's commercial strategy as the company scales operations and expands the reach of its precision neurology platform. Mr. Stockwood brings over 20 years of leadership experience in specialty diagnostics and tools, with a proven track record of commercial scaling within public and private companies. Most recently as Vice President of Sales at Quanterix, he led a global team focused on

    1/8/26 4:01:00 PM ET
    $NTRA
    Medical Specialities
    Health Care

    Phunware Announces Appointment of Elliot Han as Chairperson of the Board of Directors

    Experienced Corporate Finance and Technology/Digital-Asset Leader to Guide Board Strategy and Growth Initiatives AUSTIN, Texas, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Phunware, Inc. ("Phunware" or the "Company") (NASDAQ:PHUN), the enterprise cloud platform for mobile that provides products, solutions, data, and services for brands to engage, manage and monetize global audiences, today announced that Elliot Han was appointed Chairperson of the Company's Board of Directors and Chairperson of the Board's Audit Committee, each effective October 2025. Mr. Han has served as a Class II non-employee Director on the Company's Board since January 2024 and will continue to chair the Board's Compensation

    12/2/25 8:31:00 AM ET
    $PHUN
    EDP Services
    Technology

    $ADAG
    $BANL
    $DATS
    $ESLA
    Financials

    Live finance-specific insights

    View All

    Natera Reports Fourth Quarter and Full Year 2025 Financial Results

    Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the fourth quarter and full year ended December 31, 2025. Recent Financial Highlights Generated total revenues of $665.5 million in the fourth quarter of 2025, compared to $476.1 million in the fourth quarter of 2024, an increase of 39.8%. Product revenues grew 39.8% over the same period. Generated a gross margin1 of 66.9% in the fourth quarter of 2025, compared to a gross margin1 of 62.9% in the fourth quarter of 2024. Generated total revenues of $2,306.1 million in the full year 2025, compared to $1,696.9 million in the full year 2024, an increase of 35.9%.

    2/26/26 4:05:00 PM ET
    $NTRA
    Medical Specialities
    Health Care

    Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026

    Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its fourth quarter and year ended Dec. 31, 2025, after the market closes on Feb. 26, 2026. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET). Earnings Conference Call Information Event: Natera's Fourth Quarter & Full Year 2025 Financial Results Date: February 26, 2026 Time: 1:30 p.m. PT (4:30 p.m. ET) Live Dial-In:   1-888-770-7321 (Domestic) 1-929-201-7107 (International) Conference ID: 7684785 Webcast: https://events.q4inc.com/at

    2/17/26 9:00:00 AM ET
    $NTRA
    Medical Specialities
    Health Care

    Rail Vision CEO: Concluding 2025 with a Strong Cash Position, Zero Debt, Commercialization Gains, Global Expansion and Powerful Partnerships. Quantum Rail Innovation Ahead

    Ra'anana, Israel, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (NASDAQ:RVSN) ("Rail Vision" or the "Company"), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, today issued a corporate update to its shareholders from the Company's Chief Executive Officer, Mr. David BenDavid. Dear Shareholders, 2025 was a transformative year for Rail Vision. We are continuing the execution of our commercialization plan while we actively seek new opportunities that have the potential to provide us with sustained commercial momentum through strategic partnerships and technological leadership, while maintaining a strong balance she

    2/11/26 7:32:00 AM ET
    $RVSN
    Railroads
    Industrials

    $ADAG
    $BANL
    $DATS
    $ESLA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by LQR House Inc.

    SC 13D/A - LQR House Inc. (0001843165) (Subject)

    11/25/24 4:41:10 PM ET
    $LQR
    Beverages (Production/Distribution)
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by Verb Technology Company Inc.

    SC 13G/A - Verb Technology Company, Inc. (0001566610) (Subject)

    11/15/24 8:24:57 PM ET
    $VERB
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Salarius Pharmaceuticals Inc.

    SC 13G/A - Salarius Pharmaceuticals, Inc. (0001615219) (Subject)

    11/14/24 4:38:31 PM ET
    $SLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care